Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclogest in threatened preterm labor and uterine–fetal blood flow impedance
IRCT2016062117034N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of progesterone in Preterm labor (PTL), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Change in uterine–fetal blood flow impedance. Started Jun 2015; status: completed.
02
Drugs
progesterone
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on IRCT2016062117034N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016062117034N4.